ClinicalTrials.gg
CompletedNCT05126355Updated Nov 20, 2026Results posted

Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults

An interventional study of On the Move group exercise in Mobility Limitation, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

How we know

Updated Nov 20, 2026Now CompletedResults posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
529
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 126 studies in Mobility Limitation with a site in United States — 31 open to participants now, 35 under way, 3 of them phase 3. Mobility Limitation · United States.

Enrollment
4th of 116
529 · median 40
Started
2022
with 5 others
No phase
93 of 126
20 open now
Registered
79th of 126
by date
Lead sponsor
3 of 126
University of Pittsburgh

Among the 126 studies in Mobility Limitation with a site in United States, this one is the 4th largest by enrollment of the 116 interventional ones that give a count, is one of 6 that started in 2022, is one of 93 with no phase, and was the 79th registered.

Mobility Limitation

383 studies on the registry are indexed under Mobility Limitation; 106 are open to participants now.

Browse Mobility Limitation studies →

Open to participants now

31 of the 126 studies in Mobility Limitation with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Mobility Limitation studies recruiting now, 33 (51%) set no upper age limit and 15 (23%) stop at 75 or younger; 5 take children under 18; 9 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 126 studies in Mobility Limitation with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to test the effectiveness of On the Move (OTM) in terms of improving mobility among 502 older adults in 44 senior community centers and to evaluate intervention fidelity, including adherence and competence, and the impact of organizational, instructor, and participant level factors on intervention fidelity.

Read the detailed description

The investigators will conduct a Hybrid I trial, blending effectiveness and implementation research aims to: test the effectiveness of OTM, evaluate intervention fidelity, and determine the extent intervention fidelity moderates intervention effectiveness. The investigators will evaluate the effects of OTM taught by community instructors for improving mobility among 502 older adults in 44 community centers using a cluster randomized design with a delayed intervention control arm. Intervention fidelity will be assessed by instructor self-report (intervention diaries) and observation (fidelity checklist). Organizational, instructor, and participant level factors which may impact fidelity will be assessed via standard instruments, focus groups and interviews.

Specific Aims are as follows:

Aim 1: Establish the effectiveness of OTM on improvements in walking ability and post-intervention persistence of benefits.

Rationale: OTM delivered by research staff is effective. Establishing the effectiveness of OTM delivered by community instructors is necessary before wide-scale implementation.

Hypothesis: Compared to a randomized control group followed for 12 weeks, the OTM group will have greater gains in gait speed (primary outcome) and self-reported mobility at 12 and 24 weeks of follow-up.

Aim 2: Assess intervention fidelity (measures of adherence and competence) and identify the impact of organizational, instructor, and participant level factors on intervention fidelity.

Rationale: To inform future implementation efforts, it is critical to measure intervention fidelity and to identify factors associated with fidelity.

Hypothesis: Organizational, instructor, and participant level factors will impact fidelity. For example, instructors who utilize greater facilitation strategies will have higher fidelity, poor organizational acceptance of the program will be related to lower fidelity, and fewer organizational resources will lead to lower fidelity.

Aim 3: Determine the extent to which intervention fidelity, measured by adherence and competence, moderates the effectiveness of OTM.

Rationale: Intervention fidelity may influence the effectiveness of OTM. Understanding the consequences of differing levels of intervention fidelity on effectiveness will inform future implementation efforts.

Hypothesis: Higher fidelity will be associated with greater mobility gains, and there may be critical fidelity thresholds.

03

Conditions studied

  • Mobility Limitation

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 60 years of age or older
  • attend the senior center
  • can ambulate household distances independently
  • can participate in group exercise classes

Exclusion criteria

Exclusion Criteria:

  • impaired cognition (unable to understand consent process)
  • plans to leave the area for an extended period of time
  • any acute or unstable illness or medical condition
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
529 participants (actual)

Study arms

  • Experimental
    On the Move

    On the Move group exercise program to improve walking. Delivered twice per week for 12 weeks.

    Behavioral: On the Move group exercise

  • Other
    On the Move - Delayed

    Individuals in this arm will be placed on a wait-list for 12 weeks and will receive no intervention during this time. At the end of the 12 weeks they will receive the On the Move group exercise program. This is a wait-list control group.

    Behavioral: On the Move group exercise

Interventions

  • BehavioralOn the Move group exercise

    The OTM exercise program is a group-based program led by a certified OTM instructor. The frequency and duration of OTM is 50 minutes, twice weekly for 12 weeks for a total of 24 classes. The OTM exercise program is based on principles of motor learning that enhance smooth and automatic movement control. The program contains a warm-up (5 minutes), stepping patterns (15 minutes), walking patterns (15 minutes), strengthening exercises (10 minutes), and cool-down exercises (5 minutes). The warm-up and cool down contain gentle range of motion exercises and stretches for the lower extremities and trunk. Considered essential components, the stepping and walking patterns are progressively more difficult, goal-oriented patterns that promote the timing and coordination of stepping integrated with the phases of the gait cycle.

06

What researchers measure

Primary outcomes

  1. Change in Gait Speed From Baseline to 12 Weeks

    Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 12 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.

    Time frame: 12 weeks

  2. Change in Gait Speed From Baseline to 24 Weeks

    Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 24 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.

    Time frame: 24 weeks

Secondary outcomes

  1. Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks.

    The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. The score is reported as a standardized T-score based on the U.S. general population. The population mean is 50 and the standard deviation is 10. Typical range of scores is 20 to 80 where scores above 80 and below 20 are rare. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 12 week score minus baseline score.

    Time frame: 12 weeks

  2. 24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility

    The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 24 week score minus baseline score.

    Time frame: 24 weeks

  3. Participant Satisfaction

    Participant satisfaction will be assessed using a single item question that includes five items measured on a Likert scale. The question is "how satisfied were you with the On the Move Program?" The Likert items assess degree of satisfaction. We report the number of participants who were satisfied or very satisfied.

    Time frame: immediately post intervention

Other outcomes

  1. Adherence - Content

    We have identified the essential components of OTM. Inclusion of essential components will be determined from exercise class logs. OTM instructors will be required to keep a log of time spent on each program component in each class, for each of the 24 classes. We will review the logs and determine if the essential components (warm-up, walking, stepping patterns, strengthening exercises and cool-down) are included in each of the classes. For each of the classes offered, instructors will be classified as being fully adherent, adherent to core components only, or non-adherent.

    Time frame: Throughout the 12 week intervention

  2. Adherence - Dose of Exposure Classes Offered

    Dose of exposure classes offered will be quantified as number of classes offered by the community center (0-24). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of classes is better.

    Time frame: Throughout the 12 week intervention

  3. Adherence - Dose of Exposure, Weeks of Exercise

    Dose of exposure, weeks of exercise will be quantified as the number of weeks the exercise classes are offered (0-12). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of weeks is better.

    Time frame: Throughout the 12 week intervention

  4. Adherence - Dose of Exposure, Participant Level.

    Dose of exposure at the participant level will be quantified as the number of classes each participant attends, 0-24. The instructor will keep a class log of each session to record attendance. A greater number of classes is better.

    Time frame: Throughout the 12 week intervention

  5. Competence - Quality of Delivery

    The content experts will use a standardized checklist to document if the instructor is delivering the program with adequate skill. The checklist includes 20 items such as appropriately demonstrating exercises, modifying the exercises as needed, and progressing exercises appropriately. Competence will be quantified by the total number of items present on the checklist; scores will range from 0-20.

    Time frame: Throughout the 12 week intervention

  6. Adaptations

    Adaptations will be recorded, defined and classified using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME).

    Time frame: Throughout the 12 week intervention.

07

Results

Posted Nov 20, 2026

Participant flow

Participants were recruited between June 2022 and March 2025 from individuals receiving services from community-based organizations in southwestern Pennsylvania.

Participant flow — Overall Study
MilestoneOn the MoveOn the Move - Delayed
Started272257
12 week assessment229234
24 week assessment215213
Completed215213
Not completed5744
Withdrew: Death10
Withdrew: Withdrawal by subject4336
Withdrew: Lost to follow-up138

Outcome measures

PrimaryChange in Gait Speed From Baseline to 12 Weeks

Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 12 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.

Time frame:
12 weeks
Reported as:
Least squares mean · m/s
Change in Gait Speed From Baseline to 12 Weeks
m/sOn the MoveOn the Move - Delayed
Change in Gait Speed From Baseline to 12 Weeks0.07 ± 0.23-0.02 ± 0.24
Statistical analysis
  • On the Move vs On the Move - Delayed · Mixed Models Analysis · p = <.0001 (The p value was calculated.) · Mean difference (net): 0.09 · 95% CI 0.05 to 0.12linear mixed models with multiple imputation for missing data
PrimaryChange in Gait Speed From Baseline to 24 Weeks

Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 24 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.

Time frame:
24 weeks
Reported as:
Least squares mean · m/s
Change in Gait Speed From Baseline to 24 Weeks
m/sOn the MoveOn the Move - Delayed
Change in Gait Speed From Baseline to 24 Weeks0.07 (0.05 to 0.10)-0.02 (-0.04 to 0.01)
Statistical analysis
  • On the Move vs On the Move - Delayed · Mixed Models Analysis · p = <.0001 (The p-value was calculated) · Mean difference (net): 0.09 · 95% CI 0.06 to 0.12
SecondaryChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks.

The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. The score is reported as a standardized T-score based on the U.S. general population. The population mean is 50 and the standard deviation is 10. Typical range of scores is 20 to 80 where scores above 80 and below 20 are rare. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 12 week score minus baseline score.

Time frame:
12 weeks
Reported as:
Least squares mean · score
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks.
scoreOn the MoveOn the Move - Delayed
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks.0.7 (-0.1 to 1.6)-0.7 (-1.5 to 0.1)
Statistical analysis
  • On the Move vs On the Move - Delayed · Mixed Models Analysis · p = 0.0230 · Median difference (net): 1.4 · 95% CI 0.2 to 2.6
Secondary24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility

The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 24 week score minus baseline score.

Time frame:
24 weeks
Reported as:
Least squares mean · score
24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility
scoreOn the MoveOn the Move - Delayed
24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility0.4 (-0.4 to 1.1)-0.7 (-1.5 to 0.1)
Statistical analysis
  • On the Move vs On the Move - Delayed · Mixed Models Analysis · p = 0.0840 · Mean difference (net): 1.0 · 95% CI -0.1 to 2.2
SecondaryParticipant Satisfaction

Participant satisfaction will be assessed using a single item question that includes five items measured on a Likert scale. The question is "how satisfied were you with the On the Move Program?" The Likert items assess degree of satisfaction. We report the number of participants who were satisfied or very satisfied.

Time frame:
immediately post intervention
Reported as:
Count of participants · Participants
Participant Satisfaction
ParticipantsOn the MoveOn the Move - Delayed
Participant Satisfaction210201
Other pre-specifiedAdherence - Content

We have identified the essential components of OTM. Inclusion of essential components will be determined from exercise class logs. OTM instructors will be required to keep a log of time spent on each program component in each class, for each of the 24 classes. We will review the logs and determine if the essential components (warm-up, walking, stepping patterns, strengthening exercises and cool-down) are included in each of the classes. For each of the classes offered, instructors will be classified as being fully adherent, adherent to core components only, or non-adherent.

Time frame:
Throughout the 12 week intervention

Results for this outcome have not been posted.

Other pre-specifiedAdherence - Dose of Exposure Classes Offered

Dose of exposure classes offered will be quantified as number of classes offered by the community center (0-24). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of classes is better.

Time frame:
Throughout the 12 week intervention

Results for this outcome have not been posted.

Other pre-specifiedAdherence - Dose of Exposure, Weeks of Exercise

Dose of exposure, weeks of exercise will be quantified as the number of weeks the exercise classes are offered (0-12). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of weeks is better.

Time frame:
Throughout the 12 week intervention

Results for this outcome have not been posted.

Other pre-specifiedAdherence - Dose of Exposure, Participant Level.

Dose of exposure at the participant level will be quantified as the number of classes each participant attends, 0-24. The instructor will keep a class log of each session to record attendance. A greater number of classes is better.

Time frame:
Throughout the 12 week intervention

Results for this outcome have not been posted.

Other pre-specifiedCompetence - Quality of Delivery

The content experts will use a standardized checklist to document if the instructor is delivering the program with adequate skill. The checklist includes 20 items such as appropriately demonstrating exercises, modifying the exercises as needed, and progressing exercises appropriately. Competence will be quantified by the total number of items present on the checklist; scores will range from 0-20.

Time frame:
Throughout the 12 week intervention

Results for this outcome have not been posted.

Other pre-specifiedAdaptations

Adaptations will be recorded, defined and classified using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME).

Time frame:
Throughout the 12 week intervention.

Results for this outcome have not been posted.

Adverse events

Collected over From enrollment until the end of the 24 week follow-up. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
On the Move Immediate1/272 (0.4%)20/272 (7.4%)21/272 (7.7%)
On the Move Delayed No Exercise0/257 (0%)11/257 (4.3%)7/257 (2.7%)
On the Move Delayed - Exercise0/257 (0%)10/257 (3.9%)10/257 (3.9%)
Most frequent serious events
Showing 10 of 14
Most frequent serious events
EventOn the Move ImmediateOn the Move Delayed No ExerciseOn the Move Delayed - Exercise
SurgerySurgical and medical procedures3/2726/2573/257
FallInjury, poisoning and procedural complications5/2722/2571/257
FactureInjury, poisoning and procedural complications4/2721/2573/257
Pulmonary EdemaRespiratory, thoracic and mediastinal disorders2/2720/2570/257
Stomach PainGastrointestinal disorders0/2721/2571/257
Thromboembolic eventVascular disorders0/2720/2571/257
Upper respiratory infectionInfections and infestations0/2720/2571/257
cardiac arrestCardiac disorders0/2721/2570/257
Heart FailureCardiac disorders1/2720/2570/257
PenumothoraxRespiratory, thoracic and mediastinal disorders1/2720/2570/257
Most frequent other events
Most frequent other events
EventOn the Move ImmediateOn the Move Delayed No ExerciseOn the Move Delayed - Exercise
FallInjury, poisoning and procedural complications10/2723/2571/257
FractureInjury, poisoning and procedural complications6/2721/2575/257
Pain in extremityMusculoskeletal and connective tissue disorders5/2723/2574/257

Baseline characteristics

Age, Continuous
Age, Continuous(years)On the MoveOn the Move - DelayedTotal
Mean77.3 ± 7.576.0 ± 7.776.7 ± 7.6
Sex: Female, Male
Sex: Female, Male(Participants)On the MoveOn the Move - DelayedTotal
Female224218442
Male483987
Race (NIH/OMB)
Race (NIH/OMB)(Participants)On the MoveOn the Move - DelayedTotal
American Indian or Alaska Native011
Asian112
Native Hawaiian or Other Pacific Islander101
Black or African American84149
White258206464
More than one race268
Unknown or Not Reported224
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)On the MoveOn the Move - DelayedTotal
Hispanic or Latino235
Not Hispanic or Latino259238497
Unknown or Not Reported111627
Duke Comorbidity index
Duke Comorbidity index(units on a scale)On the MoveOn the Move - DelayedTotal
Mean2.9 ± 1.32.8 ± 1.22.8 ± 1.3
Fear of falling
Fear of falling(Participants)On the MoveOn the Move - DelayedTotal
Count of participants129124253
Fall prior year
Fall prior year(Participants)On the MoveOn the Move - DelayedTotal
Count of participants8478162
Gait speed
Gait speed(m/s)On the MoveOn the Move - DelayedTotal
Mean0.99 ± 0.240.96 ± 0.250.98 ± 0.24

2 further baseline measures are reported on the registry.

08

Study locations

1 site
09

References and documents

Publications

  • Brach JS, VanSwearingen JM, Freburger J, Weiner BJ, Zanardelli JJ, Perera S. On the Move in the community: Protocol for a hybrid 1 trial examining effectiveness and fidelity of a community-based group exercise program for older adults. Contemp Clin Trials. 2024 Oct;145:107666. doi: 10.1016/j.cct.2024.107666. Epub 2024 Aug 17. PubMed 39159805 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All collected individual participant data may be shared. Because the human subjects included in the project could potentially be identified, given the relatively limited geographic distribution of these subjects, investigators requesting data will be required to sign a data sharing agreement. For external requests, the agreement will be executed through the University's Office of Research; and for internal requests, through email.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data sets will be available at the time the primary paper is accepted for publication or at 2 years after the last participant is followed whichever comes first.

Access criteria: Data will be available by secure transfer to investigators who complete a data sharing agreement for data from this project. The sharable data will be archived at the study's home site and will be available for sharing by submitting a request to the PI. Once a request is approved by the PI and the requester agrees to the conditions for data use, the data will be transferred.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2022 to primary completion in Sep 2025, 38 months.

Results were first posted in Nov 2026, 1 year 2 months after primary completion.

Of 201 non-industry interventional studies with no phase under Mobility Limitation, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 42. This study's 38 months is above that.

Counting every sponsor, half of 206 studies reached it within 17 months; a quarter within 7 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2021
First posted
Nov 19, 2021
StartActual
Jun 23, 2022
Primary completionActual
Sep 18, 2025
CompletionActual
Aug 31, 2026
Results first posted
Nov 20, 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 20, 2026
Results
Results posted
posted Nov 20, 2026
Primary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedChange in Gait Speed From Baseline to 12 WeeksTime frame: 12 weeks
  • AddedChange in Gait Speed From Baseline to 24 WeeksTime frame: 24 weeks
  • RemovedGait speedTime frame: 12 weeks
  • RemovedGait speedTime frame: 24 weeks
Nov 20, 2026
Secondary outcomes
6 edited, 1 description edited
What changed in the outcomes
  • EditedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) mobilityMobility From Baseline to 12 Weeks.Time frame: 12 weeks
  • Edited24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) mobilityMobilityTime frame: 24 weeks
  • DescriptionParticipant Satisfaction: how it is measured was reworded
  • Editedother outcomeAdherence - Dose of exposure classes offeredExposure Classes OfferedTime frame: Throughout the 12 week intervention
  • Editedother outcomeAdherence - Dose of exposureExposure, weeksWeeks of exerciseExerciseTime frame: Throughout the 12 week intervention
  • Editedother outcomeAdherence - Dose of exposureExposure, participant levelParticipant Level.Time frame: Throughout the 12 week intervention
  • Editedother outcomeCompetence - Quality of deliveryDeliveryTime frame: Throughout the 12 week intervention
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Active, not recruiting→Completed
    Results posted
    Primary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedChange in Gait Speed From Baseline to 12 WeeksTime frame: 12 weeks
    • AddedChange in Gait Speed From Baseline to 24 WeeksTime frame: 24 weeks
    • RemovedGait speedTime frame: 12 weeks
    • RemovedGait speedTime frame: 24 weeks
    Secondary outcomes 6 edited, 1 description edited
    What changed in the outcomes
    • EditedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) mobilityMobility From Baseline to 12 Weeks.Time frame: 12 weeks
    • Edited24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) mobilityMobilityTime frame: 24 weeks
    • DescriptionParticipant Satisfaction: how it is measured was reworded
    • Editedother outcomeAdherence - Dose of exposure classes offeredExposure Classes OfferedTime frame: Throughout the 12 week intervention
    • Editedother outcomeAdherence - Dose of exposureExposure, weeksWeeks of exerciseExerciseTime frame: Throughout the 12 week intervention
    • Editedother outcomeAdherence - Dose of exposureExposure, participant levelParticipant Level.Time frame: Throughout the 12 week intervention
    • Editedother outcomeCompetence - Quality of deliveryDeliveryTime frame: Throughout the 12 week intervention
    + 4 other changes: verification date, date precision, index terms and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05126355
Responsible party
Jennifer S. Brach (Professor and Associate Dean for Faculty Affairs and Development, University of Pittsburgh) — Principal investigator
First posted
Nov 19, 2021
Start date
Jun 23, 2022
Primary completion
Sep 18, 2025
Completion
Aug 31, 2026
Results posted
Nov 20, 2026
Last update
Nov 20, 2026

Study contacts

Jennifer S Brach, PhD, PT
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion